Valuation: Phaarmasia Limited

Market Cap 560M 5.92M 5.28M 4.83M 4.4M 8.29M 8.51M 58.01M 23.19M 296M 22.24M 21.76M 936M P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 463M 4.9M 4.36M 3.99M 3.64M 6.85M 7.04M 47.96M 19.18M 245M 18.38M 17.99M 773M EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 week+2.37%
Current month+2.37%
1 month-11.26%
3 months-3.51%
6 months-18.00%
Current year-27.27%
1 week 79
Extreme 79
88.44
1 month 75.1
Extreme 75.1
96.75
Current year 67
Extreme 67
131.75
1 year 30.6
Extreme 30.6
131.75
3 years 23.6
Extreme 23.6
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Chairman 71 14/10/2010
Director/Board Member 55 09/12/2012
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.37%+141.18%+206.08% 5.92M
-3.76%-0.65%+47.41%+140.35% 1,216B
-1.45%-1.05%+46.41%+79.94% 656B
-2.24%-0.88%+32.97%+103.82% 509B
-1.06%-2.49%+47.76%+65.10% 384B
-2.27%+0.42%+74.12%+42.14% 362B
-0.10%+1.38%+32.03%+60.93% 311B
+0.13%+7.59%+12.79%+36.73% 293B
-3.80%-0.10%+43.90%+70.56% 249B
-3.96%+1.18%+36.70%+105.38% 208B
Average -1.85%-0.25%+51.53%+91.10% 418.78B
Weighted average by Cap. -2.31%+0.03%+43.53%+92.02%

Financials

2025 2026
Net sales 244M 2.58M 2.3M 2.1M 1.91M 3.61M 3.71M 25.25M 10.1M 129M 9.68M 9.47M 407M 472M 5M 4.45M 4.07M 3.71M 6.99M 7.18M 48.91M 19.56M 250M 18.75M 18.35M 789M
Net income -15.89M -168K -150K -137K -125K -235K -242K -1.65M -659K -8.42M -631K -618K -26.56M 176M 1.86M 1.66M 1.52M 1.38M 2.6M 2.67M 18.21M 7.28M 93.06M 6.98M 6.83M 294M
Net Debt -1.94M -20.5K -18.26K -16.71K -15.22K -28.68K -29.45K -201K -80.26K -1.03M -76.94K -75.28K -3.24M -96.98M -1.03M -914K -836K -762K -1.44M -1.47M -10.05M -4.02M -51.36M -3.85M -3.77M -162M
Projected Income Statement - Annual - Phaarmasia Limited
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
06/11/26 ₹82.00 0.00% 622
05/11/26 ₹82.00 -1.01% 4
04/11/26 ₹82.84 +1.02% 30
03/11/26 ₹82.00 -6.81% 232
02/11/26 ₹87.99 +9.85% 995
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock